Introduction: Glaucoma is a multifactorial disease seen as a progressive optic nerve damage and visual field flaws. -adrenergic blockers) aswell as agents owned by novel medication classes with original mechanisms of actions. Novel goals and compounds examined in clinical studies consist of an actin polymerization inhibitor (ie, latrunculin), Rho-associated proteins kinase inhibitors, adenosine receptor analogs,… Continue reading Introduction: Glaucoma is a multifactorial disease seen as a progressive optic